drugset

drugset / Trial / NCT00722852

Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee

NCT00722852 ↗

Phase 3 Completed 555 enrolled IDEA AG

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to provide replicated evidence of safety and efficacy of 100 mg ketoprofen in Diractin®.

Timeline

Start: 2008-06
Primary completion: 2009-02
Completion: 2009-04

Publications

Rother M, Conaghan PG. A randomized, double-blind, phase III trial in moderate osteoarthritis knee pain comparing topical ketoprofen gel with ketoprofen-free gel. J Rheumatol. 2013 Oct;40(10):1742-8. doi: 10.3899/jrheum.130192. Epub 2013 Sep 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ketoprofen	Small molecule	100 mg	Topical

Indications